肾炎康复片联合缬沙坦治疗糖尿病肾病临床疗效评价

    The clinical effect of nephritis rehabilitation tablet combined with valsartan in the treatment of diabetic nephropathy

    • 摘要: 目的:观察肾炎康复片联合缬沙坦治疗糖尿病肾病(DN)的临床疗效。方法:选择患DN者120例随机分为肾炎康复片组(A组)44例,缬沙坦组(B组)41例,肾炎康复片联合缬沙坦联合给药组(C组)35例,3组患者均连续控制血糖和血压治疗3周以上,分别给予肾炎康复片、氯沙坦及二者联合治疗,连续给药12周。比较3组患者的尿微量清蛋白、尿转铁蛋白水平检测结果,并记录不良反应。结果:治疗后C组患者的尿微量清蛋白、尿转铁蛋白水平均低于A组和B组(P0.01);3组不良反应发生率差异无统计学意义(P0.05)。结论:肾炎康复片联合缬沙坦治疗DN的效果较单一用药治疗效果好,临床上可以安全应用。

       

      Abstract: Objective:To observe the clinical effects of nephritis rehabilitation tablet combined with valsartan in the treatment of diabetic nephropathy.Methods:One hundred and twenty patients with diabetic nephropathy were randomly divided into group A(nephritis rehabilitation tablet group,44 cases),group B(valerian group,41 cases) and group C(combination nephritis rehabilitation tablet with valerian group,35 cases).The three groups were treated with nephritis rehabilitation tablet,Valerian and nephritis rehabilitation tablet combined with valerian for 12 weeks after blood glucose and blood pressure were controlled more than 3 weeks,respectively.The urinary microalbumin,urinary transferring and adverse reactions in three groups were recorded.Results:The levels of urinary microalbumin and urinary transferring in group C were lower than those in group A and B(P 0.01).The differences of adverse reactions in three groups were not statistical significance (P 0.05).Conclusions:The effects of nephritis rehabilitation tablet combined with valsartan for treating diabetic nephropathy are better than single drug treatment,and safety in clinical application.

       

    /

    返回文章
    返回